Diodes Inc DIOD
New risk paragraphs, branching off last year
Each branch is a paragraph in Risk Factors with nothing like it in the 10-K filed Feb 14, 2025. A box jumps to the paragraph as filed, below.
Paragraphs with nothing like them in last year's 10-K
1 paragraph in Risk Factors of the 10-K filed Feb 10, 2026 with nothing like it in the 10-K filed Feb 14, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.
strikes, or labor shortages could cause our product costs to rise and/or could cause manufacturing partners on whom we rely to exit the business. These events could have a material adverse impact on our product availability and quality, which would affect our business, operating results, and financial condition.
Paragraphs in the 10-Q filed Nov 5, 2026 that were not in the one before
New in the latest 10-Q
57 paragraphs in the 10-Q filed Nov 5, 2026 with nothing like them in the 10-Q filed Aug 5, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.
Financial statements and notes
NOTE 2 - Earnings per Share and Equity Earnings per share (“EPS”) is calculated by dividing net income attributable to common stockholders by the weighted-average number of shares of Common Stock outstanding during the period. Diluted EPS is calculated similarly but includes potential dilution from the exercise of stock options and stock awards, except when the effect would be anti-dilutive. No dividends were paid on our Common Stock in any of the periods presented in this report. On May 8, 2025, the Board of Directors authorized a share repurchase program pursuant to which the Company may repurchase shares of its common stock from time to time in the open market or through privately negotiated transactions, subject to market conditions, applicable legal requirements, and other factors. The repurchased shares are held as treasury stock and are excluded from shares outstanding for purposes of calculating basic and diluted earnings per share from the date of repurchase. The following table sets forth repurchase activity under the program during the periods presented: Three Months Ended Nine Months Ended September 30, September 30, 2026 2025 2026 2025 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Shares repurchased 360.12 459.24 210.94 Aggregate purchase price $ 35,000 $ $ 45,197 $10,004 Average purchase price per share $ 97.19 $ $ 98.42 $47.42 During the nine months ended September 30, 2026, our 53% owned subsidiary, ERIS, reduced its ownership interest in one of its subsidiaries from approximately 96% to approximately 77%, which increased the Company’s noncontrolling interest in ERIS by approximately $9.9 million. The Company received approximately $25.3 million. On August 18, 2026, the Company issued $375.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031 (the "Convertible Senior Notes"). The Convertible Senior Notes require the Company to settle the principal amount in cash upon conversion, with any conversion premium payable in cash, shares of the Company's common stock, or a combination thereof. The Company accounts for the potential dilutive effect of the Convertible Senior Notes in accordance with the if-converted method.
Read in the 10-Q
Because the principal amount of the Convertible Senior Notes is required to be settled in cash, only the incremental shares, if any, attributable to the conversion premium are included in diluted weighted-average shares outstanding, and no adjustment is made to the numerator for interest expense. Shares issuable upon conversion are included in diluted weighted-average shares outstanding only to the extent required under the if-converted method. For the three and nine months ended September 30, 2026, no incremental shares attributable to the Convertible Senior Notes were included in diluted earnings per share because the average market price of the Company's common stock did not exceed the conversion price during the applicable periods. In connection with the issuance of the Convertible Senior Notes, the Company entered into Capped Call Transactions (the "Capped Call Transactions") that are expected to reduce potential dilution to the Company's common stock upon conversion of the Convertible Senior Notes and/or offset cash payments in excess of the principal amount of converted Convertible Senior Notes. The Capped Call Transactions have an initial strike price of approximately $145.79 per share, which corresponds to the initial conversion price of the Convertible Senior Notes, and an initial cap price of approximately $194.38 per share, in each case subject to certain adjustments under the terms of the Capped Call Transactions. The Capped Call Transactions initially cover, subject to anti-dilution adjustments, approximately 2.6 million shares of common stock underlying the Convertible Senior Notes. The Company paid premiums of approximately $21.9 million for the Capped Call Transactions, which were recorded as a reduction to additional paid-in capital, net of the related deferred tax benefit. Because the Capped Call Transactions meet the criteria for classification within stockholders’ equity and are classified within stockholders' equity, they are not subsequently remeasured at fair value. The Capped Call Transactions are excluded from the calculation of diluted earnings per share because their inclusion would be antidilutive. The table below sets forth the reconciliation between net income and the weighted-average shares outstanding used for calculating basic and diluted EPS: Three Months Ended Nine Months Ended September 30, September 30, 2026 2025 2026 2025 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Earnings (numerator) Net income attributable to common stockholders $ 43,712 $ 14,278 $ 105,322 $ 55,939 Shares (denominator) Weighted-average common shares outstanding (basic) 45,878 46,383 45,906 46,384 Dilutive effect of stock options and stock awards outstanding 369 54 427 70 Adjusted weighted-average common shares outstanding (diluted) 46,247 46,437 46,333 46,454 Earnings per share attributable to common stockholders Basic $ 0.95 $ 0.31 $ 2.29 $ 1.21 Diluted $ 0.95 $ 0.31 $ 2.27 $ 1.20 Stock options and stock awards excluded from EPS 356 273 127 674
Read in the 10-Q
On August 18, 2026, the Company completed a private offering of $375.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031 (the "Convertible Senior Notes"), including the exercise in full of the initial purchasers' option to purchase an additional $50.0 million aggregate principal amount. The Convertible Senior Notes were issued pursuant to an Indenture, dated August 18, 2026 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee. The Convertible Senior Notes are senior unsecured obligations of the Company and mature on August 15, 2031, unless earlier converted, redeemed, or repurchased. The Convertible Senior Notes do not bear regular interest, and the principal amount does not accrete. Special interest may accrue under certain circumstances as provided in the Indenture.
Read in the 10-Q
The initial conversion rate of the Convertible Senior Notes is 6.8594 shares of the Company's common stock per $1,000 principal amount of Convertible Senior Notes, which represents an initial conversion price of approximately $145.79 per share. As of September 30, 2026, the conversion rate had not been adjusted.
Read in the 10-Q
Prior to May 15, 2031, holders may convert their Convertible Senior Notes only upon the occurrence of certain events and during specified periods as set forth in the Indenture. On or after May 15, 2031, holders may convert the Convertible Senior Notes at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Upon conversion, the Company is required to settle the principal amount of the Convertible Senior Notes in cash and may settle any conversion value in excess of the principal amount in cash, shares of the Company's common stock, or a combination thereof, at its election, in accordance with the terms of the Indenture.
Read in the 10-Q
Show the other 52
The conversion rate is subject to adjustment upon the occurrence of certain events in accordance with the terms of the Indenture. In addition, following certain corporate events that occur prior to the maturity date, or if the Company issues a notice of redemption, the Company may be required to increase the conversion rate for holders who elect to convert their Convertible Senior Notes in connection with such events.
Read in the 10-Q
The Convertible Senior Notes are not redeemable by the Company prior to August 20, 2029. On or after August 20, 2029, and prior to the 31st scheduled trading day immediately preceding maturity, the Company may redeem all or a portion of the Convertible Senior Notes for cash, subject to certain conditions, including that the last reported sale price of the Company's common stock is at least 130% of the then-applicable conversion price for a specified period. The redemption price equals 100% of the principal amount of the Convertible Senior Notes being redeemed, plus any accrued and unpaid special interest to, but excluding, the redemption date.
Read in the 10-Q
The Company received net proceeds of approximately $364.8 million from the offering after deducting the initial purchasers' discounts, commissions and offering expenses and prior to giving effect to the cost of the Capped Call Transactions described below. The Company used approximately $21.9 million of the net proceeds to pay premiums for the Capped Call Transactions and approximately $35.0 million to repurchase approximately 0.4 million shares of its common stock. The Company expects to use the remaining net proceeds for general corporate purposes, including potential future acquisitions.
Read in the 10-Q
The Convertible Senior Notes are accounted for as a single liability measured at amortized cost. Debt issuance costs associated with the Convertible Senior Notes are presented as a reduction of the carrying amount of the Convertible Senior Notes and are amortized to interest expense over the contractual term of the Convertible Senior Notes using the effective interest method. As of September 30, 2026, the carrying amount of the Convertible Senior Notes was $364.9 million, consisting of $375.0 million in principal amount, net of $10.1 million of unamortized debt issuance costs. For the three and nine months ended September 30, 2026, the Company recognized $0.2 million of interest expense related to the amortization of debt issuance costs. The effective interest rate on the Convertible Senior Notes was approximately 0.55%.
Read in the 10-Q
In connection with the issuance of the Convertible Senior Notes, the Company entered into privately negotiated Capped Call Transactions (the “Capped Call Transactions”) with certain financial institutions. The Capped Call Transactions are expected generally to reduce the potential dilution to the Company's common stock upon any conversion of the Convertible Senior Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of Convertible Senior Notes, as the case may be. The Capped Call Transactions have an initial strike price of approximately $145.79 per share, which corresponds to the initial conversion price of the Convertible Senior Notes, and an initial cap price of $194.38 per share, subject to customary adjustments under the terms of the Capped Call Transactions.
Read in the 10-Q
The Capped Call Transactions cover, subject to customary adjustments, the number of shares of the Company's common stock initially underlying the Convertible Senior Notes. The Capped Call Transactions are generally expected to reduce potential dilution to the Company's common stock upon conversion of the Convertible Senior Notes and/or offset any cash payments the Company is required
Read in the 10-Q
to make in excess of the principal amount of converted Convertible Senior Notes, subject to the cap. The Capped Call Transactions are separate transactions entered into by the Company and are not part of the terms of the Convertible Senior Notes. Holders of the Convertible Senior Notes do not have any rights with respect to the Capped Call Transactions.
Read in the 10-Q
The Company paid premiums of approximately $21.9 million for the Capped Call Transactions, which were recorded within stockholders' equity as a reduction to additional paid-in capital, net of the related deferred tax benefit. The Capped Call Transactions are generally expected to reduce dilution resulting from conversion of the Convertible Senior Notes to the extent that the market price of the Company's common stock exceeds the initial conversion price of the Convertible Senior Notes, subject to the cap price. Because the Capped Call Transactions are classified in stockholders' equity, they are not subsequently remeasured at fair value.
Read in the 10-Q
Non-Current Assets Non-Current Liabilities 2026 2025 2026 2025 Derivatives with hedge designations Collared forwards $ $ 11,454 $ 964 $ 2,558 Commodity swap contracts $ $ - $ 884 $ - Derivatives without hedge designations Foreign exchange forwards $ $ - $ - $ - The table below sets forth the effect of the Company’s derivative financial instruments on the Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2026 and 2025: Derivative Instruments Amount of Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion Excluded from Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing) Designated as September 30, Effectiveness September 30, Hedging Instruments 2026 2025 Testing) 2026 2025 Three Months Ended ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Collared forwards $ (649) $ 17,491 Interest income $ 1,800 $ 6,176 Commodity swap contracts $ 266 $ - Cost of goods sold $ (162) N/A Nine Months Ended Collared forwards $ (2,144) $ 3,700 Interest income $ 8,418 $ 15,484 Commodity swap contracts $ (1,522) $ - Cost of goods sold $ (162) N/A During the three months ended September 30, 2026 and 2025, the Company recognized gains of approximately $1.8 million and $6.2 million, respectively, related to collared forward contracts in interest income. During the three months ended September 30, 2026, the Company recognized losses of approximately $0.2 million related to commodity swap contracts in cost of goods sold, increasing cost of goods sold expense by the same amount. No amounts related to commodity swap contracts were recognized in earnings during the three months ended September 30, 2025. During the nine months ended September 30, 2026 and 2025, the Company recognized gains of approximately $8.4 million and $15.5 million, respectively, related to collared forward contracts in interest income. During the nine months ended September 30, 2026, the Company recognized losses of approximately $0.2 million related to commodity swap contracts in cost of goods sold, increasing cost of goods sold expense by the same amount. No amounts related to commodity swap contracts were recognized in earnings during the nine months ended September 30, 2025.
Read in the 10-Q
Keylink is a 5% joint venture partner in our Shanghai assembly and test facilities. We sell products to, and purchase inventory from, companies owned by Keylink. In addition, our subsidiaries in China lease their manufacturing facilities in Shanghai from, and subcontract a portion of our manufacturing process (metal plating and environmental services) to Keylink. We also pay a consulting fee to Keylink. Warren Chen, a member of the Company’s board of directors, serves as a member of the Nuvoton board of directors. In the nine months ended September 30, 2026, we purchased approximately $1.4 million of wafers from Nuvoton under an agreement that ended in the second quarter of 2026. We consider our relationship with Nuvoton to be mutually beneficial, and plan to continue our strategic alliance with Nuvoton. JCP is a frequency control product manufacturing company from which we purchase material and in which we have made an equity investment that we account for using the equity method of accounting. Atlas is an early stage privately held fabless wafer design company in which the Company holds a majority interest. The Company determined that Atlas is a variable interest entity (“VIE”), and the Company does not have the power to direct the activities that most significantly impact Atlas. The Company has therefore determined that the Company is not the primary beneficiary. Consequently, we do not consolidate the assets and liabilities of Atlas in the Company’s financial statements. For additional information related to Atlas see Note 14 - Equity Investments - Unconsolidated VIE, below. In June 2025, the Company entered into a Joint Venture Agreement to acquire a 43% interest and joint control of ATX, a Malaysian private limited liability company, with the purpose of building synergies related to testing and packaging. ATX is a related party for the Company. The table below sets forth the revenues and expenses with our related parties: Three Months Ended Nine Months Ended September 30, September 30, 2026 2025 2026 2025 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Keylink: Net sales $78 $(37) $87 $(10) Purchases $339 $6 $804 $205 Plating, rental, and consulting expense $4,104 $3,438 $11,581 $9,966 Nuvoton: Net sales $1 $3 $27 $56 Purchases $1,158 $2,218 $6,421 $4,561 JCP: Purchases $- $- $- $105 Atlas: Purchases $1,397 $2,055 $5,750 $8,793 ATX: Purchases $224 $- $520 $- The table below sets forth accounts receivable from, and accounts payable to, our related parties: September 30, 2026 December 31, 2025 ────────────────────────────────────────────────────────────────────── Keylink: Accounts receivable $31,974 $25,415 Accounts payable $35,488 $27,837 Nuvoton: Accounts receivable $- $9 Accounts payable $1,011 $1,131 Atlas: Accounts payable $369 $721 ATX: Accounts payable $73 $12
Read in the 10-Q
NOTE 14 - Equity Investments The Company maintains equity investments in companies which are accounted for under the measurement alternative described in ASC 321-10-35-2 for equity securities that lack readily determinable fair values. As of September 30, 2026 and December 31, 2025, the Company had $97.7 million and $97.4 million, respectively, of investments accounted for under the measurement alternative. During
Read in the 10-Q
Note 15 - Acquisitions and dispositions ElevATE Semiconductor Acquisition On August 27, 2026, (the “Acquisition Date”) the Company closed its acquisition of 100% of the outstanding equity interests of ElevATE, a developer of highly integrated, low-power analog and mixed-signal semiconductor solutions for semiconductor test
Read in the 10-Q
applications. The acquisition expands Diodes' analog and mixed-signal product portfolio and strengthens the Company's position in attractive, high-growth end markets driven by increasing semiconductor complexity and test intensity. The total aggregate purchase price was $267.1 million and total net consideration was $238.7 million after adjusting for cash acquired. The purchase price was funded with our available cash. The acquisition agreement provides for additional contingent payments of up to $50.0 million upon the achievement of specified revenue and gross margin targets. The acquisition-date fair value of the contingent consideration was approximately $4.9 million, determined using a Monte Carlo simulation based on the probability and timing of achieving the applicable revenue thresholds. The contingent consideration was recorded in other long-term liabilities and is remeasured at fair value at each subsequent reporting date, as a level 3 fair value measurement, with changes in fair value recognized in earnings. As of September 30, 2026, the fair value of the contingent consideration liability was $4.9 million. The table below sets forth the estimated fair value of the purchase consideration: Cash paid to acquire outstanding equity interests of ElevATE $262,274 Fair value of contingent consideration 4,876 Transaction costs paid on seller's behalf (4) Purchase consideration $267,146 The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. Accordingly, the assets acquired and liabilities assumed were recognized at their estimated acquisition-date fair values, with the excess of consideration transferred over the fair value of identifiable net assets acquired recognized as goodwill. The following table summarizes the preliminary purchase price allocation: Estimated fair value of assets acquired: Cash and cash equivalents 28,477 Accounts receivable 4,350 Inventories 28,000 Prepaid expenses and other current assets 227 Property, plant, and equipment 4,337 Intangible assets 199,000 Other long-term assets 655 Total assets acquired 265,046 Estimated fair value of liabilities assumed: Accounts payable 781 Accrued liabilities and other 32,199 Other long-term liabilities 416 Deferred tax liabilities 45,193 Total liabilities assumed 78,589 Total identifiable net assets 186,457 Goodwill 80,689 Purchase consideration $267,146 The excess of the total equity value of ElevATE over net assets acquired was recorded as goodwill. The goodwill is primarily attributable to the synergies expected to arise from the integration of ElevATE's technologies and product portfolio with the Company's existing operations, as well as the value of the assembled workforce. None of the goodwill is expected to be deductible for tax purposes. The intangible assets acquired as a result of the acquisition consisted of developed technologies, in-process research & development (“IPR&D”), customer contracts and related relationships, and trademarks, the finite-lived assets will be amortized over the estimated useful life. The approximate fair values of the developed technologies, IPR&D, customer contracts and related relationships and trademarks is $64.0 million, $15.0 million, $115.0 million and $5.0 million, respectively. The fair value of developed technologies, IPR&D, and trademarks were valued using a Relief-from-royalty (“RfR”) Method. The RfR method estimates the fair value of an intangible asset by calculating the present value of the hypothetical royalty payments that would have been required if the Company did not own the asset and instead licensed it from a third party. The fair value of customer contracts and related relationships were valued using a Multi-Period Excess Earnings method. The Multi-Period Excess Earning method model estimates revenues and cash flows derived from the asset and then deductions portions of the cash flow that can be attributed to supporting assets. Finite-lived intangible assets are amortized over their estimated useful lives, which range from 11 to 23 years. Estimated future amortization expense is approximately $3.5 million in 2026 and $13.9 million in each of 2027, 2028, 2029, 2030, and 2031. Acquired IPR&D assets are classified as indefinite-lived intangible assets and are not amortized until the underlying projects are completed, at
Read in the 10-Q
which time the assets are evaluated for their estimated useful lives and amortization begins. If an IPR&D project is abandoned, the related asset is evaluated for impairment. The Company incurred approximately $2.0 million of acquisition related expenses, which primarily consisted of transaction fees and legal, accounting and other professional services that are included in the accompanying unaudited condensed consolidated statements of operations within Selling, general, and administrative expenses. These costs were expensed as incurred. The purchase price allocation is preliminary and subject to adjustment during the measurement period, which will not exceed one year from the acquisition date. The Company is continuing to evaluate the acquisition-date fair values of certain assets acquired and liabilities assumed, including intangible assets, inventory, and the related income tax effects. The preliminary amounts may be adjusted as additional information regarding facts and circumstances existing as of the Acquisition Date becomes available. Any qualifying measurement-period adjustments will be recognized in the reporting period in which the adjustments are determined, with the corresponding effect generally recorded to goodwill. Unaudited Pro Forma Financial Information The amounts of revenue and earnings of ElevATE included in the Company's consolidated statement of operations from the acquisition date to the period ending September 30, 2026 are as follows (in thousands): August 28, 2026 September 30, 2026 ───────────────────────────────────────────────── Net sales $ 1,925 Net income 219 The following unaudited pro forma summary presents consolidated information of the Company as if the acquisition and consolidation of ElevATE had occurred on January 1, 2025: Three months ended Nine Months Ended September 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025 ────────────────────────────────────────────────────────────────────────────────────────────────────────────── Net sales $543,238 $396,484 $1,404,422 $1,109,971 Net income $37,417 $9,451 $95,278 $43,436 The unaudited pro forma consolidated results of operations do not purport to be indicative of the results that would have been obtained if the above acquisition had actually occurred as of the dates indicated or of those results that may be obtained in the future. The unaudited pro forma consolidated results for the three months and nine months ended September 30, 2026, include adjustments that result in an increase to amortization expense of $3.5 million and $10.4 million, respectively, an additional $0.6 million and $1.7 million in interest expense, respectively, and a reduction of $0.3 million and $0.4 million of share based compensation expense, respectively. The income tax impact of these adjustments was $0.8 million and $2.5 million for the three and nine months ended September 30, 2026, respectively. The unaudited pro forma consolidated results for the three months and nine months ended September 30, 2025, include adjustments that result in an increase to amortization expense of $3.5 million and $10.4 million, respectively, an additional $0.6 million and $1.7 million in interest expense, respectively, a reduction of $0.1 million and $0.4 million of share based compensation expense, respectively, and an additional $2.4 million and $9.2 million of cost of goods sold, respectively. The income tax impact of these adjustments was $1.3 million and $4.4 million for the three and nine months ended September 30, 2025, respectively. These unaudited pro forma consolidated results of operations were derived, in part, from the historical consolidated financial statements of ElevATE and other available information and assumptions believed to be reasonable under the circumstances. TF Semiconductor Solutions, Inc. Agreement and Plan of Merger During the three months ended September 30, 2026, the Company received 29,249 shares of Microchip Technology Incorporated (“MCHP”) common stock as additional consideration related to the 2025 sale of its investment in TF Semiconductor Solutions, Inc (“TFSS”). The shares were recorded at fair value upon receipt. The Company sold 13,025 shares, receiving approximately $1.0 million, during the three months ended September 30, 2026 and retained the remaining shares as of September 30, 2026. The Company recorded deferred consideration of approximately $1.3 million in connection with the disposition, representing the estimated fair value of MCHP shares expected to be received from the indemnity fund. Upon execution of a settlement agreement with MCHP with respect to purchase price and indemnification matters, the final amount of consideration became fixed. As a result, the Company recognized an increase in the value of the previously recorded share consideration from approximately $1.3 million to $2.4 million and the $2.8 million earnout
Read in the 10-Q
cash consideration that had not previously met the recognition criteria due to uncertainty surrounding the contingency. The aggregate gain recognized during the three months ended September 30, 2026 was approximately $3.8 million.
Read in the 10-Q
On August 18, 2026, we issued $375.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031 (the "Convertible Senior Notes"), including the exercise in full of the initial purchasers' option to purchase an additional $50.0 million aggregate principal amount. The Convertible Senior Notes were issued pursuant to an Indenture, dated August 18, 2026 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee. The Convertible Senior Notes are senior unsecured obligations of the Company and mature on August 15, 2031, unless earlier converted, redeemed, or repurchased. The Convertible Senior Notes do not bear regular interest, and the principal amount does not accrete. Special interest may accrue under
Read in the 10-Q
certain circumstances as provided in the Indenture. Also in August 2026, in connection with the pricing of the Convertible Senior Notes and the exercise by the initial purchasers of their option in full to purchase additional notes, we entered into the Capped Call Transactions with several financial institutions, including one or more of the initial purchasers and/or their respective affiliates.
Read in the 10-Q
The Company’s third quarter revenue reached record levels coupled with an over 500-basis point year-over-year increase in gross margin to 36.1%, with global point of sales reaching record level in the quarter. The Company’s over 19% sequential revenue growth was primarily driven by continued market share gains in the automotive market, improving demand across broad industrial applications, and continued momentum in the artificial intelligence ecosystem. Underpinning this growth is the benefit of the targeted investments we made in capacity expansion over the past year coming online.
Read in the 10-Q
Our primary sources of liquidity consist of cash and cash equivalents, cash generated from operations, availability under our Revolving Credit Facility, and access to capital markets. Our primary uses of cash include working capital requirements, capital expenditures, strategic acquisitions, debt service obligations, stock repurchases, and other general corporate purposes.
Read in the 10-Q
At September 30, 2026 and December 31, 2025, working capital was $1.1 billion and $878.6 million, respectively. At September 30, 2026 our cash and cash equivalents and restricted cash totaled $566.2 million.
Read in the 10-Q
During the three months ended September 30, 2026, the Company completed the financing transactions described below designed to enhance our financial flexibility, strengthen our long-term capital structure, and support future growth initiatives. Collectively, these transactions enhanced our capital structure by providing long-term financing, extending debt maturities, and increasing available liquidity while maintaining borrowing capacity under our Revolving Credit Facility.
Read in the 10-Q
In August 2026, we issued $375.0 million aggregate principal amount of 0.00% Convertible Senior Notes (“Convertible Senior Notes”) due 2031. Net proceeds from the offering were approximately $364.8 million, after deducting initial purchaser discounts, commissions, and offering expenses and prior to giving effect to the cost of the Capped Call Transactions described below. We used approximately $21.9 million to fund the Capped Call Transactions, and approximately $35.0 million for concurrent repurchases of our common stock. The remaining proceeds are available for general corporate purposes, including potential future acquisitions.
Read in the 10-Q
The issuance of the Convertible Senior Notes significantly increased our available liquidity and provided a long-term source of capital with no scheduled cash interest payments. As a result we are able to preserve our substantial cash balances while maintaining capacity under our Revolving Credit Facility for future operating, investing, and strategic activities.
Read in the 10-Q
Concurrently with the issuance of the Convertible Senior Notes, we entered into Capped Call Transactions intended to reduce potential dilution associated with conversions of the Convertible Senior Notes, subject to the terms of the transactions. The aggregate premium paid for the Capped Call Transactions was approximately $21.9 million.
Read in the 10-Q
Also during August 2026, we amended our Credit Agreement, extending the maturity date of our Revolving Credit Facility to August 12, 2031, modifying pricing provisions, permitting the Convertible Senior Notes financing, and revising certain financial and negative covenants. The amended facility continues to provide an important source of committed liquidity and financial flexibility. There were no borrowings outstanding under the Credit Agreement at September 30, 2026.
Read in the 10-Q
At September 30, 2026, there was no outstanding balance under the Credit Agreement and approximately $225.0 million remained available for borrowing. In August 2026, we amended the Credit Agreement, extending the maturity or the Revolving Credit Facility to
Read in the 10-Q
August 12, 2031 and modifying certain terms to provide additional financial flexibility. The Credit Agreement contains customary affirmative and negative covenants, including a maximum leverage ratio and a minimum interest coverage ratio. As of September 30, 2026, we were in compliance with all financial covenants under the facility.
Read in the 10-Q
In August 2026, we issued $375.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031. The issuance provided long-term capital, increased available liquidity, and preserves the borrowing capacity under our Revolving Credit Facility. The Convertible Senior Notes do not bear regular interest and, unless earlier converted, redeemed, or repurchased, mature on August 15, 2031.
Read in the 10-Q
Additionally, our 53% owned subsidiary, ERIS, had long-term debt of $17.5 million and $25.0 million, at September 30, 2026 and December 31, 2025, respectively, from local Taiwan banks. These borrowings mature at various dates through 2033.
Read in the 10-Q
offset by $21.9 million for the Capped Call Transactions and approximately $45.2 million used to repurchase the Company’s common stock.
Read in the 10-Q
Controls and procedures
On August 27, 2026, the Company acquired ElevATE Semiconductor. Management excluded ElevATE from its assessment of internal control over financial reporting as of September 30, 2026. This exclusion is in accordance with SEC guidance that permits an acquired business to be omitted from management's assessment of internal control over financial reporting during the first year following an acquisition. ElevATE represented approximately $265.0 million of total assets and $1.9 million of revenue included in the Company's consolidated financial statements as of and for the period ended September 30, 2026. Other than activities related to the integration of ElevATE, there were no changes in the Company's internal control over financial reporting during the quarter that materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.
Read in the 10-Q
Risk Factors
We may not have the ability to raise the funds necessary to settle conversions of our Convertible Senior Notes or to repurchase our Convertible Senior Notes upon a fundamental change, and our Credit Agreement contains, and any future debt may also contain, limitations on our ability to pay cash upon conversion or repurchase of our Convertible Senior Notes.
Read in the 10-Q
Holders of our Convertible Senior Notes have the right, subject to certain conditions and limited exceptions, to require us to repurchase all or a portion of their Convertible Senior Notes upon the occurrence of a fundamental change (as defined in the Indenture) at a fundamental change repurchase price equal to 100% of the principal amount of our Convertible Senior Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date. In addition, upon any conversion of our Convertible Senior Notes, we will be required to make cash payments for each $1,000 in principal amount of our Convertible Senior Notes converted of at least the lesser of $1,000 and the sum of the daily conversion values as described in the Convertible Senior Notes Indenture. However, we may not have enough available cash or be able to obtain financing at the time we are required to make repurchases of our Convertible Senior Notes surrendered therefor or pay cash with respect to our Convertible Senior Notes being converted. In addition, our Credit Agreement prohibits us from making any cash payments on the conversion or repurchase of our Convertible Senior Notes if an event of default exists thereunder, making any cash payments upon a fundamental change or if, after giving effect to such conversion or repurchase (and any additional indebtedness incurred in connection with such conversion or a repurchase), we would not be in pro forma compliance with our financial covenants under that facility. Our ability to repurchase our Convertible Senior Notes or to pay cash upon conversions of our Convertible Senior Notes may be limited by law, by regulatory authority or by agreements governing our future indebtedness. Our failure to repurchase our Convertible Senior Notes at a time when the repurchase is required by the Indenture or to pay any cash payable on future conversions of our Convertible Senior Notes as required by the Indenture would constitute a default under the Indenture. A default under the Indenture or the fundamental change itself could also lead to a default under agreements governing our indebtedness. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness and repurchase our Convertible Senior Notes or make cash payments upon conversions thereof.
Read in the 10-Q
The conditional conversion feature of our Convertible Senior Notes, if triggered, may adversely affect our financial condition and operating results.
Read in the 10-Q
In the event the conditional conversion feature of our Convertible Senior Notes is triggered, holders of our Convertible Senior Notes will be entitled to convert their notes at any time during specified periods at their option. If one or more holders elect to convert their notes, we would be required to settle any converted principal amount of such notes through the payment of cash, which could adversely affect our liquidity. In addition, even if holders do not elect to convert their notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of our Convertible Senior Notes as a current rather than long-term liability, which would result in a material reduction of our working capital.
Read in the 10-Q
Conversion of our Convertible Senior Notes may dilute the ownership interest of our stockholders or may otherwise depress the price of our common stock.
Read in the 10-Q
The conversion of some or all of our Convertible Senior Notes may dilute the ownership interests of our stockholders. Upon conversion of our Convertible Senior Notes, we have the option to pay or deliver, as the case may be, cash, shares of our common stock, or a combination of cash and shares of our common stock in respect of the remainder, if any, of our conversion obligation in excess of the aggregate principal amount of our Convertible Senior Notes being converted. If we elect to settle the remainder, if any, of our conversion obligation in excess of the aggregate principal amount of our Convertible Senior Notes being converted in shares of our common stock or a combination of cash and shares of our common stock, any sales in the public market of our common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of our Convertible Senior Notes may encourage short selling by market participants because the conversion of our Convertible Senior Notes could be used
Read in the 10-Q
to satisfy short positions, or anticipated conversion of our Convertible Senior Notes into shares of our common stock could depress the price of our common stock.
Read in the 10-Q
Changes in the accounting method for convertible debt securities that may be settled in cash, such as our Convertible Senior Notes, could adversely affect our reported financial condition and results.
Read in the 10-Q
The accounting method for reflecting our Convertible Senior Notes on our balance sheet, accruing interest expense for our Convertible Senior Notes and reflecting the underlying shares of our common stock in our reported diluted earnings per share may adversely affect our reported earnings and financial condition.
Read in the 10-Q
In August 2020, the Financial Accounting Standards Board published ASU 2020-06, which simplifies certain of the accounting standards that apply to convertible notes. In accordance with ASU 2020-06, our Convertible Senior Notes are reflected as a liability on our balance sheets, with the initial carrying amount equal to the principal amount of our Convertible Senior Notes, net of issuance costs. The issuance costs were treated as a debt discount for accounting purposes, which will be amortized into interest expense over the term of our Convertible Senior Notes. As a result of this amortization, the interest expense that we expect to recognize for our Convertible Senior Notes for accounting purposes will be greater than the cash interest payments we will pay on our Convertible Senior Notes, which will result in lower reported net income.
Read in the 10-Q
In addition, the shares of our common stock underlying our Convertible Senior Notes are reflected in our diluted earnings per share using the “if converted” method, in accordance with ASU 2020-06. Under that method, diluted earnings per share generally are calculated assuming that all of our Convertible Senior Notes were converted into cash and shares of common stock at the beginning of the reporting period based on the average market price of common stock determined in accordance with applicable accounting rules, unless the result would be anti-dilutive. The application of the if-converted method may reduce our reported diluted earnings per share.
Read in the 10-Q
Furthermore, if any of the conditions to the convertibility of our Convertible Senior Notes is satisfied, then we may be required under applicable accounting standards to reclassify the liability carrying value of our Convertible Senior Notes as a current, rather than a long-term, liability. This reclassification could be required even if no noteholders convert their notes and could materially reduce our reported working capital.
Read in the 10-Q
Certain provisions in the Indenture governing the Convertible Senior Notes may delay or prevent an otherwise beneficial takeover attempt of us.
Read in the 10-Q
Certain provisions in the Indenture may make it more difficult or expensive for a third party to acquire us. For example, the Indenture will require us, subject to limited exceptions, to repurchase our Convertible Senior Notes for cash upon the occurrence of a fundamental change and, in certain circumstances, to increase the conversion rate for a holder that converts its Convertible Senior Notes in connection with a make-whole fundamental change. A takeover of us may trigger the requirement that we repurchase our Convertible Senior Notes and/or increase the conversion rate, which could make it costlier for a potential acquirer to engage in such takeover. Such additional costs may have the effect of delaying or preventing a takeover of us that would otherwise be beneficial to investors.
Read in the 10-Q
In connection with the issuance of our Convertible Senior Notes, we entered into the Capped Call Transactions with the option counterparties (the “option counterparties”). The Capped Call Transactions cover, subject to customary adjustments substantially similar to those applicable to our Convertible Senior Notes, the number of shares of our common stock initially underlying our Convertible Senior Notes. The Capped Call Transactions are expected generally to reduce the potential dilution to our common stock upon any conversion of our Convertible Senior Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted notes, as the case may be, with such reduction and/or offset subject to a cap.
Read in the 10-Q
The option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock or other securities of ours in secondary market transactions following the pricing of our Convertible Senior Notes and prior to the maturity of our Convertible Senior Notes (and are likely to do so during any observation period related to a conversion of our Convertible Senior Notes or, to the extent we exercise the relevant election under the Capped Call Transactions, following any repurchase or redemption of our Convertible Senior Notes). This activity could also cause or avoid an increase or a decrease in the market price of our common stock.
Read in the 10-Q
We are subject to counterparty risk with respect to the Capped Call Transactions.
Read in the 10-Q
The option counterparties are financial institutions, and we will be subject to the risk that one or more of the option counterparties may default or otherwise fail to perform, or may exercise certain rights to terminate, their obligations under the Capped Call Transactions. Our exposure to the credit risk of the option counterparties will not be secured by any collateral.
Read in the 10-Q
Global economic conditions have from time to time resulted in the actual or perceived failure or financial difficulties of many financial institutions and could adversely affect the option counterparties’ performance under the Capped Call Transactions. If an option counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure at that time under the Capped Call Transactions with such option counterparty. Our exposure will depend on many
Read in the 10-Q
factors but, generally, our exposure will increase if the market price or the volatility of our common stock increases. In addition, upon a default or other failure to perform, or a termination of obligations, by an option counterparty, we may suffer adverse tax consequences or more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the option counterparties.
Read in the 10-Q
In addition, the terms of the Capped Call Transactions may be subject to adjustment, modification or, in some cases, renegotiation in the event of certain corporate and other transactions. The Capped Call Transactions may not operate as we intend in the event that we are required to adjust the terms of such instruments as a result of transactions in the future or in the event of other unanticipated developments that may adversely affect the functioning of the Capped Call Transactions.
Read in the 10-Q
The 10-Q's risk factors against the 10-K
Item 1A of the 10-Q filed Nov 5, 2026 against Item 1A of the 10-K filed Feb 10, 2026.
A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed.
Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed,
Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal
(cut words struck through, new words highlighted).
Text on the page, not a score; each links to the filing at sec.gov.
What the 10-Q itself says about its risk factors:There have been no material changes to our risk factors from those disclosed in the Risk Factors section of our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission on February 10, 2026 except as follows:
Read in the 10-Q
Show the other 7
The first 12 of 21 are shown (at most 12 of each type).
Phrases used for the first time
Two-word phrases in Risk Factors of the 10-K filed Feb 10, 2026 that are in none of the 1 earlier 10-Ks stored, back to Feb 14, 2025
Where each one is used
- deferred tax: Exclusive of one-time deferred tax charges of $0.9 million and $1.6 million for the twelve months ended December 31, 2025 and 2024, the impact of tax holidays decreased our tax expense by approximately $1.3 million, $1.1 million, and $0.7 million for the twelve months ended December 31, 2025, 2024, and 2023,...
- tax charges: Exclusive of one-time deferred tax charges of $0.9 million and $1.6 million for the twelve months ended December 31, 2025 and 2024, the impact of tax holidays decreased our tax expense by approximately $1.3 million, $1.1 million, and $0.7 million for the twelve months ended December 31, 2025, 2024, and 2023,...
- one-time deferred: Exclusive of one-time deferred tax charges of $0.9 million and $1.6 million for the twelve months ended December 31, 2025 and 2024, the impact of tax holidays decreased our tax expense by approximately $1.3 million, $1.1 million, and $0.7 million for the twelve months ended December 31, 2025, 2024, and 2023,...
Used at least twice, small words left out. Counted, not picked: a phrase can be new because the company renamed something.
Sources
Item 1A of each 10-K and 10-Q on EDGAR, quoted exactly. Each paragraph links to the filing at sec.gov.
Also
10-K change: what was reworded or cut, section by section.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/DIOD/export.csv") into a cell.